Biphenyl

Biphenyl

SCHEMBL7466723

CC(=O)c1[nH]cc(C)c1C.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 2/20 0.46
HTT P42858 1/20 0.37
MAP2 P11137 1/20 0.37
BRPF1 P55201 1/20 0.37
RPA1 P27694 1/20 0.36
MCL1 Q07820 1/20 0.36
NOTUM Q6P988 1/20 0.36
SGK1 O00141 1/20 0.36
PBRM1 Q86U86 1/20 0.36
BRD4 O60885 1/20 0.36
CYP1A2 P05177 1/20 0.36
CACNA1D Q01668 1/20 0.36
RAB9A P51151 1/20 0.36
KMO O15229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5960571 0.87 NOTUM (0.40) BRPF1NOTUMPBRM1BRD4CYP1A2
SCHEMBL29750764 0.82 CCNC (0.51) SMN1; SMN2MAPTHTTMAP2SGK1
SCHEMBL9748278 0.74 NOTUM (0.50) SMN1; SMN2MAPTHTTRPA1MCL1
SCHEMBL1585807 0.73 RPA1 (0.51) MAPTHTTMAP2RPA1MCL1
SCHEMBL15197092 0.72 ALDH1A1 (0.44) SMN1; SMN2MAPTBRPF1PBRM1RAB9A
SCHEMBL7687945 0.71 SMN1; SMN2 (0.56) SMN1; SMN2MAPTHTTNOTUMCYP1A2
SCHEMBL14023416 0.69 NOTUM (0.48) SMN1; SMN2MAPTBRPF1NOTUMBRD4
SCHEMBL20157257 0.69 CCNC (0.51) SMN1; SMN2NOTUM
Biphenyl SCHEMBL15332958 0.68 SMN1; SMN2 (0.67) SMN1; SMN2MAPTHTTRAB9AKMO
Biphenyl SCHEMBL1822628 0.68 SMN1; SMN2 (0.67) SMN1; SMN2MAPTHTTRAB9AKMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5674879-A Compositions including and methods of using conformationally restricted angiotensin II antagonist G.D. SEARLE & CO. (US) 1997-10-07 US disclosed
US-5426105-A Cardiovascular disorders G.D. SEARLE & CO. (US) 1995-06-20 US disclosed